About
Team
Portfolio
Insights
About
Team
Portfolio
Insights
Biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases
Biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases
Sectors
Healthcare
Life Sciences
First Invested
2010
Early
Company Status
IPO/Public
NASDAQ: RYTM
Board Members
Edward Mathers
Website
Rhythm Pharmaceuticals